Sharing Our Strength: A Research Study for Bone Marrow/Stem Cell Transplant Survivors

Study Overview
=================
Brief Summary
-----------------
The Sharing Our Strength study is being conducted to help us understand people's experiences with hematopoietic stem cell transplantation and to test a new program designed to help people recover physically and emotionally after transplant.

Detailed Description
-----------------
This is a study for survivors of hematopoietic stem cell transplantation (also known as bone marrow transplant), which is an intensive medical treatment for cancers such as leukemia, lymphoma, and multiple myeloma as well as other diseases. Because it is a physically and emotionally demanding treatment, many people report having ongoing physical and emotional difficulties after having a transplant. The Sharing Our Strength study is being conducted to help us understand people's transplant experiences and to test a new program designed to help them recover physically and emotionally after transplant. All parts of the study are completed by mail and telephone. Participants will receive compensation for their time.

Official Title
-----------------
Sharing Our Strength: A Research Study for Bone Marrow/Stem Cell Transplant Survivors

Conditions
-----------------
Leukemia, Acute Leukemia, Acute Lymphocytic Leukemia, Multiple Myeloma, Hematological Cancers, Psychological Distress

Intervention / Treatment
-----------------
* Behavioral: Writing A (Experimental informative writing)
* Behavioral: Writing B (Experimental noninformative writing)
* Behavioral: Writing C (Control informative writing)
* Behavioral: Writing D (Control noninformative writing)


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Be a transplant survivor who is 9 months to 3 years beyond transplant and not currently relapsed. and not currently relapsed Be at least 18 years old now (and at least 16 when they had their transplant) Speak English Have telephone service Exclusion Criteria: None

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Treatment
Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: Double


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: Experimental Writing Type 1<br> | Behavioral: Writing A (Experimental informative writing)<br>* Experimental informative writing<br>|
| Experimental: Experimental Writing type 2<br> | Behavioral: Writing B (Experimental noninformative writing)<br>* Experimental noninformative writing<br>|
| Active Comparator: Control writing type 1<br> | Behavioral: Writing C (Control informative writing)<br>* Control informative writing<br>|
| Placebo Comparator: Control writing type 2<br> | Behavioral: Writing D (Control noninformative writing)<br>* Control noninformative writing<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Psychological Adjustment |  | At screening, baseline and 3 months following intervention | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Quality of Life |  | At screening, baseline and 3 months following intervention | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Aplastic Anemia, Lymphatic Diseases, Leukemia, Leukemia, Lymphoid, Immunoproliferative Disorders, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Anemia, Quality of Life, Lymphoproliferative Disorders, Lymphoma, Multiple Myeloma